Tech Company M&A Transactions
EKR Therapeutics Acquisition
On 5/16/2012, EKR Therapeutics was purchased by Cornerstone Therapeutics. Purchase price was estimated to be $150 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/16/2012
Transaction Type
M&A
Amount
$150,000,000
M&A Terms
Under the terms of the agreement, Cornerstone will make an initial cash payment of approximately $125 million, subject to adjustment in accordance with the terms of the merger agreement, and make certain additional payments contingent upon the achievement of certain milestones related to regulatory approval of a new active ingredient supplier for RETAVASE and sales of RETAVASE during approximately the first three years following commercial relaunch.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1545 US Highway 206
Bedminster, NJ 07921
USA
Bedminster, NJ 07921
USA
Phone
Website
Email Address
Overview
Headquartered in Bedminster, New Jersey, EKR Therapeutics is a specialty pharmaceutical company focused on the acute-care hospital setting. EKR is committed to serving the needs of this important segment of the healthcare market by providing novel products offering broader therapeutic potential and superior outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Bailye
Chief Operating Officer
Bill McKee
VP - Bus. Development
Bryan Stuart
VP - Operations
Susan Bacso
VP - Sales
Jon Zwinski
Browse more venture capital transactions:
Prev: 5/16/2012: Prosodic venture capital transaction
Next: 5/16/2012: Lenddo venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs